Track topics on Twitter Track topics that are important to you
VANCOUVER, Nov. 29, 2018 /PRNewswire/ - BlueBird Battery Metals Inc. (TSXV: BATT; US: BBBMF) (the "Company" or "BlueBird") is pleased to announce results from the Read more...
NEW YORK, Dec. 5, 2018 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of bluebird bio, Inc. ("bluebird" or the "Company") (NASDAQ: BLUE). Such investors are advised t...
bluebird bio (NASDAQ:BLUE) has announced the opening of its first wholly owned manufacturing facility in Durham, North Carolina, which will produce lentiviral vector for its investigational gene and c...
Phase 1 data on a dozen patients hint that bb21217 may deliver the efficacy and persistence that Bluebird and partner Celgene have been vying for.
bluebird bio (WKN:A1W025) hatte ein hartes Jahr 2018. Das Unternehmen hat jedoch immer noch eine Marktkapitalisierung von 6,5 Mrd. US-Dollar, obwohl es keine Medikamente auf dem Markt hat. Um diese...
NC's Gov. Cooper to cut ribbon on facility that will strengthen bluebird's capabilities to make products for clinical devt. and commercial supply
A licensing deal has been completed between Bluebird Bio and Inhibrx that will focus on research, development and commerciali -More-
Enrollment is completed for the midstage trial by Bluebird Bio and partner Celgene to evaluate the experimental chimeric anti -More-
A total of 50 poultry farms of commercial broilers (N = 39) and commercial layers (N = 11) suffered from respiratory problems and mortality during the period from January 2016 to December 2017 were in...
This is a multi-center, long-term safety and efficacy follow-up study for subjects with hemoglobinopathies (β-thalassemia or severe sickle cell disease) who have been treated with ex vivo...
bluebird bio, Inc. bluebird bio to Present Updated Clinical Results from Ongoing Multicenter Phase 1 Study of bb2121 Anti- BCMA CAR T Cell Therapy in Patients with Late Stage Relapsed/Refractory Multiple Myeloma at ASCO Annual Meeting
bluebird bioÂ is developing innovative gene therapies for severe genetic disorders.Â At the heart of bluebird bioâs product creation efforts is its broadly applicable gen...
The REVOLUTION Medicines team brings deep expertise and a track record of building exceptional life sciences companies. In addition to Dr. Goldsmith, founding president and...
We have published hundreds of bluebird bio, Inc. news stories on BioPortfolio along with dozens of bluebird bio, Inc. Clinical Trials and PubMed Articles about bluebird bio, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of bluebird bio, Inc. Companies in our database. You can also find out about relevant bluebird bio, Inc. Drugs and Medications on this site too.
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...
Cardiology is a specialty of internal medicine. Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...